JP2024503898A5 - - Google Patents
Info
- Publication number
- JP2024503898A5 JP2024503898A5 JP2023544070A JP2023544070A JP2024503898A5 JP 2024503898 A5 JP2024503898 A5 JP 2024503898A5 JP 2023544070 A JP2023544070 A JP 2023544070A JP 2023544070 A JP2023544070 A JP 2023544070A JP 2024503898 A5 JP2024503898 A5 JP 2024503898A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- independently
- sulfur
- oxygen
- heteroatoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163140523P | 2021-01-22 | 2021-01-22 | |
| US63/140,523 | 2021-01-22 | ||
| US202163202524P | 2021-06-15 | 2021-06-15 | |
| US63/202,524 | 2021-06-15 | ||
| PCT/US2022/070308 WO2022159976A1 (en) | 2021-01-22 | 2022-01-24 | Rapamycin analogs and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024503898A JP2024503898A (ja) | 2024-01-29 |
| JP2024503898A5 true JP2024503898A5 (https=) | 2025-02-03 |
Family
ID=82549982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023544070A Pending JP2024503898A (ja) | 2021-01-22 | 2022-01-24 | ラパマイシン類似体及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220267352A1 (https=) |
| EP (1) | EP4281463A4 (https=) |
| JP (1) | JP2024503898A (https=) |
| KR (1) | KR20230136625A (https=) |
| AU (1) | AU2022209863A1 (https=) |
| BR (1) | BR112023014287A2 (https=) |
| CA (1) | CA3209086A1 (https=) |
| MX (1) | MX2023008634A (https=) |
| WO (1) | WO2022159976A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL285067B2 (en) | 2019-01-22 | 2025-02-01 | Aeovian Pharmaceuticals Inc | MTORC Modulators and Their Uses |
| CN115776907B (zh) | 2020-03-27 | 2025-02-25 | 艾奥维安制药公司 | Mtorc1调节剂及其用途 |
| GB202415232D0 (en) | 2024-10-16 | 2024-11-27 | Nacamed As | Composition |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA935110B (en) * | 1992-07-17 | 1994-02-04 | Smithkline Beecham Corp | Rapamycin derivatives |
| JP2010500286A (ja) * | 2006-07-25 | 2010-01-07 | アボット・ラボラトリーズ | 結晶形態のラパマイシン類似体 |
| EP2558092B1 (en) * | 2010-04-13 | 2018-06-27 | Novartis AG | Combination comprising a cyclin dependent kinase 4 or cyclin dependent kinase 6 (cdk4/6) inhibitor and an mtor inhibitor for treating cancer |
| WO2012017449A1 (en) * | 2010-08-04 | 2012-02-09 | Meril Life Sciences Pvt. Ltd | Process for preparation of novel 42-0-(heteroalkoxyalkyl) rapamycin compounds with anti-proliferative properties" |
| US10683308B2 (en) * | 2015-09-11 | 2020-06-16 | Navitor Pharmaceuticals, Inc. | Rapamycin analogs and uses thereof |
| WO2019241789A1 (en) * | 2018-06-15 | 2019-12-19 | Navitor Pharmaceuticals, Inc. | Rapamycin analogs and uses thereof |
| WO2020076738A2 (en) * | 2018-10-12 | 2020-04-16 | Bellicum Pharmaceuticals, Inc | Protein-binding compounds |
| IL285067B2 (en) * | 2019-01-22 | 2025-02-01 | Aeovian Pharmaceuticals Inc | MTORC Modulators and Their Uses |
| AU2020397938A1 (en) * | 2019-12-05 | 2022-06-23 | Janssen Pharmaceutica Nv | Rapamycin analogs and uses thereof |
-
2022
- 2022-01-24 US US17/648,750 patent/US20220267352A1/en not_active Abandoned
- 2022-01-24 MX MX2023008634A patent/MX2023008634A/es unknown
- 2022-01-24 CA CA3209086A patent/CA3209086A1/en active Pending
- 2022-01-24 JP JP2023544070A patent/JP2024503898A/ja active Pending
- 2022-01-24 AU AU2022209863A patent/AU2022209863A1/en not_active Abandoned
- 2022-01-24 BR BR112023014287A patent/BR112023014287A2/pt unknown
- 2022-01-24 WO PCT/US2022/070308 patent/WO2022159976A1/en not_active Ceased
- 2022-01-24 KR KR1020237027812A patent/KR20230136625A/ko active Pending
- 2022-01-24 EP EP22743426.3A patent/EP4281463A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023506410A5 (https=) | ||
| JP2024503898A5 (https=) | ||
| JP6134046B1 (ja) | 医療で使用されるインドール誘導体 | |
| WO2018013597A4 (en) | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors | |
| JP2019520417A5 (https=) | ||
| JP2021502387A5 (https=) | ||
| JP2022548095A5 (https=) | ||
| JP2018505898A5 (https=) | ||
| JP2022545359A5 (https=) | ||
| JP2009513703A5 (https=) | ||
| JP2024524766A5 (https=) | ||
| JP2022510683A5 (https=) | ||
| JP2011515482A5 (https=) | ||
| JP2022511477A5 (https=) | ||
| JP2017524005A5 (https=) | ||
| JP2010510237A5 (https=) | ||
| JP2018535963A5 (https=) | ||
| JP2020502047A5 (https=) | ||
| JP7778745B2 (ja) | Ｒｈｏ関連コイルドコイル含有プロテインキナーゼの阻害剤 | |
| JP2023531517A5 (https=) | ||
| JP2011509309A5 (https=) | ||
| JP2018515623A5 (https=) | ||
| CN115605479A (zh) | 吡啶酮并嘧啶类衍生物、其制备方法及其在医药上的应用 | |
| JP2010533699A5 (https=) | ||
| JP2021521178A5 (https=) |